[Hemodynamic effects of a combination of theophylline and ethylenediamine in heart failure with pulmonary hypertension].
D000328:Adult; D001022:Aortic Valve Insufficiency / Q000188:drug therapy; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D005029:Ethylenediamines / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006349:Heart Valve Diseases / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000188:drug therapy; D008946:Mitral Valve Stenosis / Q000188:drug therapy; D011651:Pulmonary Artery / Q000187:drug effects; D013268:Stimulation, Chemical; D013806:Theophylline / Q000627:therapeutic use*
D005029:Ethylenediamines; D013806:Theophylline
Hämodynamische Wirkungen einer Kombination von Theophyllin und Athylendiamin bei Herzfehlern mit pulmonaler Hypertension.